Singapore markets closed

PAVmed Inc. (PAVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.0600-0.0500 (-4.50%)
At close: 04:00PM EDT
1.0800 +0.02 (+1.89%)
After hours: 04:23PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 10.00M
Enterprise value 37.22M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.74
Price/book (mrq)7.42
Enterprise value/revenue 12.34
Enterprise value/EBITDA -0.33

Trading information

Stock price history

Beta (5Y monthly) 0.72
52-week change 3-82.72%
S&P500 52-week change 323.76%
52-week high 39.0000
52-week low 31.0400
50-day moving average 31.7726
200-day moving average 33.0829

Share statistics

Avg vol (3-month) 362.28k
Avg vol (10-day) 374.19k
Shares outstanding 59.43M
Implied shares outstanding 69.43M
Float 88.58M
% held by insiders 16.28%
% held by institutions 114.17%
Shares short (15 May 2024) 4379.36k
Short ratio (15 May 2024) 46.67
Short % of float (15 May 2024) 44.42%
Short % of shares outstanding (15 May 2024) 44.02%
Shares short (prior month 15 Apr 2024) 4406.87k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 307 Dec 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 0.00%
Operating margin (ttm)-1,389.70%

Management effectiveness

Return on assets (ttm)-76.10%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)3.02M
Revenue per share (ttm)0.39
Quarterly revenue growth (yoy)126.50%
Gross profit (ttm)N/A
EBITDA -59.64M
Net income avi to common (ttm)-71.05M
Diluted EPS (ttm)-9.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)27.88M
Total cash per share (mrq)2.96
Total debt (mrq)49.69M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.54
Book value per share (mrq)-7.71

Cash flow statement

Operating cash flow (ttm)-48.78M
Levered free cash flow (ttm)-25M